Equities

Healthy Extracts Inc

HYEX:QBB

Healthy Extracts Inc

Actions
  • Price (USD)1.01
  • Today's Change-2.75 / -73.14%
  • Shares traded200.00
  • 1 Year change-83.32%
  • Beta2.0428
Data delayed at least 15 minutes, as of Sep 19 2024 17:34 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Healthy Extracts Inc had net income fall 151.54% from a loss of 983.12k to a larger loss of 2.47m despite a 10.41% increase in revenues from 2.25m to 2.49m. An increase in the selling, general and administrative costs as a percentage of sales from 101.41% to 155.50% was a component in the falling net income despite rising revenues.
Gross margin67.83%
Net profit margin-47.73%
Operating margin-22.81%
Return on assets-53.40%
Return on equity-173.87%
Return on investment-168.81%
More ▼

Cash flow in USDView more

In 2023, cash reserves at Healthy Extracts Inc fell by 46.21k. Cash Flow from Financing totalled 369.54k or 14.87% of revenues. In addition the company used 415.75k for operations while cash from investing was breakeven.
Cash flow per share-0.5081
Price/Cash flow per share--
Book value per share0.1336
Tangible book value per share-0.1053
More ▼

Balance sheet in USDView more

Healthy Extracts Inc has a Debt to Total Capital ratio of 71.31%.
Current ratio0.8389
Quick ratio0.2059
Total debt/total equity2.49
Total debt/total capital0.7131
More ▼

Growth rates in USD

Year on year, growth in earnings per share excluding extraordinary items dropped -146.17%.
EPS growth(5 years)--
EPS (TTM) vs
TTM 1 year ago
31.33
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.